Sudhakar Chintharlapalli

Company: Rayzebio

Job title: Vice President & Head of Biology & Translational

Seminars:

Uncovering Strategy & Rationale Behind Novel Targets GPC3, CA9 & Disclosing Brand New Target 2:30 pm

Designing novel radiopharmaceutical drugs with precision Sharing design choices for enhanced efficacy Revealing new directions with novel targetRead more

day: Conference Day One